IP Strategy and Consulting
Intellectual Property Rights (IPRs) are often regarded as an opportunistic option and expensive evil to exclude others from using proprietary technologies, products or methods. However, Intellectual Property Rights are more than that; they can be used as strategic tools and eminent assets to achieve the business objectives of a company.It is BDC’s aim, in close cooperation with the customer’s management, to turn the companies Intellectual Property assets into Intellectual Capital for the benefit and growth of the enterprise. In this context, BDC’s unique approach is to combine BDC’s knowledge in the field of Intellectual Property Rights with that of the strategic aspects of business development.
BDC offers the following services in Intellectual Property Rights Strategy and Consulting:
- Establishing and implementing a tailor made Intellectual Property strategy... []
- Due Diligence and assessment of Intellectual Property Rights
- Positioning of the existing/future Intellectual Property Rights portfolio
- Search for third parties Intellectual Property Rights and Freedom to Operate analysis
- Education and tutoring courses, seminars and workshops in Intellectual Property matters (german only)... []
Case Example
Establishment and Implementation of an IP–Strategy for a Polymer Producer
Pursuant to the business strategy of an innovative company, intellectual property (IP) assets are valuable and important strategic tools for the growth of the company. IP rights such as patents,... []Achievements
- Regular seminars and workshops in the field of intellectual property strategy and implementation, some of them under the patronage of the WIPO, EPO or EC
- Assisting young start-up companies in setting up customized IP strategies including its operational implementation
- Positioning and validation of existing patent portfolios comprising 20 to 30 patent families or more
- Up to 10 intellectual property assessments every year for start-up companies in their venture capital fund raising processes
- Regular establishment of freedom to operate analysis especially for medium to big sized companies in Life Sciences
Printable version